randomized [resa]
Trial [resa]
Estrogen [horm, phsu, strd]
Plus [qlco]
Progestin [horm, phsu, strd]
Secondary Prevention [topp]
coronary heart disease [dsyn]
postmenopausal [tmco]
Women [popg]
Context [fndg]
Observational Study [resa]
Found [qnco]
Lower [spco]
Rate [acty]
coronary heart disease [dsyn]
postmenopausal [tmco]
Women [popg]
Take [hlca]
Estrogen [horm, phsu, strd]
Women [popg]
Not [ftcn]
Potential [qlco]
Benefit [qnco]
Not [ftcn]
confirmed [qlco]
Clinical Trials [resa]
Objective [inpr]
To [qlco]
If [qlco]
estrogen therapy [topp]
Plus [qlco]
Progestin [horm, phsu, strd]
Altered [ftcn]
Risk [qlco]
coronary heart disease [dsyn]
Events [evnt]
postmenopausal [tmco]
Women [popg]
Established [qlco]
Coronary Disease [dsyn]
Design [acty]
randomized [resa]
Blinded [resa]
placebo-controlled [resa]
Secondary Prevention [topp]
Trial [resa]
setting [ftcn]
Out-patient [podg]
Community [geoa]
setting [ftcn]
Clinical Center [orgt]
participants [popg]
Women [popg]
Coronary Disease [dsyn]
Young [tmco]
postmenopausal [tmco]
Intact [qlco]
Uterus [bpoc]
Mean [qnco]
Age [orga]
intervention [hlca]
mg% [qnco]
Conjugated Equine Estrogens [horm, phsu, strd]
mg% [qnco]
medroxyprogesterone acetate [horm, phsu, strd]
I- [inch]
Tablet [bodm]
Daily [tmco]
N NOS [aapp, imft]
placebo [topp]
Identical [qlco]
Appearance [orga]
N NOS [aapp, imft]
Average [qnco]
Assigned [ftcn]
hormone treatment [topp]
End [spco]
End [spco]
Main [qlco]
Outcome Measures [qnco]
Primary [qlco]
Outcome [ftcn]
occurrence [ftcn]
Myocardial Infarction [dsyn]
coronary heart disease [dsyn]
Death [orgf]
secondary [neop]
CARDIOVASCULAR [bdsy]
Outcome [ftcn]
included [ftcn]
coronary revascularisation [topp]
Angina, Unstable [dsyn]
Congestive heart failure [dsyn]
Resuscitated Cardiac Arrest [fndg]
Stroke [dsyn]
Transient Ischemic Attack [dsyn]
peripheral arterial disease [dsyn]
Mortality [qnco]
considered [idcn]
Result [ftcn]
Overall [inpr]
Group [idcn]
Primary [qlco]
Outcome [ftcn]
secondary [neop]
CARDIOVASCULAR [bdsy]
Outcome [ftcn]
Women [popg]
Hormone [horm]
Group [idcn]
Women [popg]
placebo [topp]
Group [idcn]
Myocardial Infarction [dsyn]
coronary heart disease [dsyn]
Death [orgf]
Relative [famg]
Hazard [qlco]
Confidence Interval [qnco]
lack [qlco]
Overall [inpr]
Effect [qlco]
Occurred [acty]
Reticular [spco]
Lower [spco]
Low density lipoprotein cholesterol level [lbpr]
High density lipoprotein cholesterol level [lbpr]
Hormone [horm]
Group [idcn]
Compared [acty]
placebo [topp]
Group [idcn]
P NOS [aapp, imft]
Overall [inpr]
Null [qnco]
Effect [qlco]
statistically significant [qnco]
Time [tmco]
trend [tmco]
More [ftcn]
coronary heart disease [dsyn]
Events [evnt]
Hormone [horm]
Group [idcn]
placebo [topp]
Group [idcn]
Few [qnco]
More [ftcn]
Women [popg]
Hormone [horm]
Group [idcn]
placebo [topp]
Group [idcn]
experience [menp]
Venous [bpoc]
Thromboembolic events [patf]
Relative [famg]
Hazard [qlco]
Confidence Interval [qnco]
Gall Bladder Disease [dsyn]
Relative [famg]
Hazard [qlco]
Confidence Interval [qnco]
Several [qnco]
End Point [qlco]
Power [hcpp]
Limited [ftcn]
Including [ftcn]
Fracture [inpo]
Cancer [neop]
Mortality [qnco]
deaths [orgf]
Relative [famg]
Hazard [qlco]
Confidence Interval [qnco]
Conclusions [idcn]
Average [qnco]
Follow-up [fndg]
treatment [ftcn]
Oral [spco]
Conjugated estrogen + medroxyprogesterone [horm, phsu, strd]
Equine [mamm]
Plus [qlco]
Acetate [orch, phsu]
Not [ftcn]
Overall [inpr]
Rate [acty]
coronary heart disease [dsyn]
Events [evnt]
postmenopausal [tmco]
Women [popg]
Established [qlco]
Coronary Disease [dsyn]
treatment [ftcn]
Increase [ftcn]
Rate [acty]
Thromboembolic events [patf]
Gall Bladder Disease [dsyn]
Based [ftcn]
Finding [sosy]
Overall [inpr]
CARDIOVASCULAR [bdsy]
Benefit [qnco]
Pattern [spco]
Early [tmco]
Increase [ftcn]
Risk [qlco]
coronary heart disease [dsyn]
Events [evnt]
Not [ftcn]
recommend [idcn]
Start [tmco]
treatment [ftcn]
Purpose [ftcn]
Secondary Prevention [topp]
coronary heart disease [dsyn]
GIVEN [cnce]
Favorable [qlco]
Pattern [spco]
coronary heart disease [dsyn]
Events [evnt]
Several [qnco]
therapy [ftcn]
Appropriate [qlco]
Women [popg]
Receive [qlco]
treatment [ftcn]
Continue [idcn]
